PAM
FOLD

Panagora Asset Management’s Amicus Therapeutics FOLD Stock Holding History

Panagora Asset Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,448,678
Closed -$11.4M – 1206
2025
Q3 		$11.4M Buy
1,448,678
+4,571
+0.3% +$32.5K 0.05% 267
2025
Q2 		$8.27M Sell
1,444,107
-811
-0.1% -$5.23K 0.04% 280
2025
Q1 		$11.8M Buy
1,444,918
+10,641
+0.7% +$98.5K 0.06% 236
2024
Q4 		$13.5M Buy
1,434,277
+4,934
+0.3% +$51.3K 0.06% 209
2024
Q3 		$15.3M Sell
1,429,343
-1,580
-0.1% -$17.2K 0.07% 195
2024
Q2 		$14.2M Sell
1,430,923
-98,239
-6% -$1.01M 0.07% 184
2024
Q1 		$18M Buy
1,529,162
+131,850
+9% +$1.69M 0.09% 174
2023
Q4 		$19.8M Sell
1,397,312
-33,112
-2% -$376K 0.11% 160
2023
Q3 		$17.4M Buy
1,430,424
+96,980
+7% +$1.25M 0.11% 161
2023
Q2 		$16.7M Sell
1,333,444
-33,521
-2% -$398K 0.1% 185
2023
Q1 		$15.2M Buy
1,366,965
+123,604
+10% +$1.52M 0.1% 194
2022
Q4 		$15.2M Buy
1,243,361
+32,356
+3% +$364K 0.1% 207
2022
Q3 		$12.6M Buy
1,211,005
+112,208
+10% +$1.25M 0.09% 212
2022
Q2 		$11.8M Buy
1,098,797
+92,665
+9% +$763K 0.08% 233
2022
Q1 		$9.53M Buy
1,006,132
+35,951
+4% +$337K 0.05% 291
2021
Q4 		$11.2M Buy
970,181
+238,275
+33% +$2.66M 0.06% 276
2021
Q3 		$6.99M Buy
731,906
+128,051
+21% +$1.31M 0.04% 360
2021
Q2 		$5.82M Buy
603,855
+308,267
+104% +$3.01M 0.03% 410
2021
Q1 		$2.92M Sell
295,588
-228,601
-44% -$3.54M 0.02% 614
2020
Q4 		$12.1M Sell
524,189
-504,395
-49% -$10.3M 0.07% 240
2020
Q3 		$14.5M Sell
1,028,584
-480,968
-32% -$7.01M 0.09% 195
2020
Q2 		$22.8M Sell
1,509,552
-35,267
-2% -$430K 0.15% 140
2020
Q1 		$14.3M Buy
1,544,819
+1,065,675
+222% +$10.1M 0.1% 190
2019
Q4 		$4.67M Buy
+479,144
New +$4.39M 0.02% 506
2016
Q1 		– Sell
-7,670
Closed -$74K – 2308
2015
Q4 		$74K Sell
7,670
-4,160
-35% -$37.5K ﹤0.01% 1876
2015
Q3 		$165K Sell
11,830
-21,592
-65% -$339K ﹤0.01% 1661
2015
Q2 		$473K Sell
33,422
-32,860
-50% -$395K ﹤0.01% 1350
2015
Q1 		$721K Buy
+66,282
New +$584K ﹤0.01% 1190

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Panagora Asset Management's FOLD Position: Q4 2025 in Review

Panagora Asset Management sold out of Amicus Therapeutics (FOLD) in Q4 2025, closing a stake of 1,448,678 shares — an estimated $11.4M sold.

Panagora Asset Management first reported a position in FOLD in Q1 2015 and held it in 28 quarters. The position peaked at $22.8M in Q2 2020. 332 funds tracked by Wall St. Rank hold FOLD as of Q4 2025.

  • Panagora Asset Management reported no remaining Amicus Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Panagora Asset Management sold 1,448,678 Amicus Therapeutics shares in Q4 2025, an estimated $11.4M.
  • Panagora Asset Management first reported a position in Amicus Therapeutics in Q1 2015 and held it in 28 quarters.
  • Panagora Asset Management's Amicus Therapeutics position peaked at $22.8M in Q2 2020.
  • 332 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2025.

Based on Panagora Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.